CSXRX | VFINX | CSXRX / VFINX | |
Total Expense Ratio | 0.19 | 0.14 | 136% |
Annual Report Gross Expense Ratio | 0.29 | 0.14 | 207% |
Fund Existence | 8 years | 49 years | - |
Gain YTD | 11.585 | 13.277 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.94B | 1.37T | 0% |
Annual Yield % from dividends | 0.90 | 1.07 | 84% |
Returns for 1 year | 13.92 | 16.14 | 86% |
Returns for 3 years | 83.66 | 86.00 | 97% |
Returns for 5 years | 99.55 | 98.33 | 101% |
Returns for 10 years | N/A | 241.91 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FHCCX | 38.90 | 0.64 | +1.67% |
Fidelity Advisor Health Care C | |||
VMGIX | 114.41 | 1.01 | +0.89% |
Vanguard Mid-Cap Growth Index Investor | |||
MSGRX | 13.34 | 0.11 | +0.83% |
Meridian Small Cap Growth Institutional | |||
KLGAX | 55.72 | 0.17 | +0.31% |
NYLI WMC Growth Class A | |||
ETIEX | 14.44 | -0.02 | -0.14% |
Eventide Exponential Technologies I |